MYDRIASERT

This brand name is authorized in Austria, Spain, Finland, France, Netherlands, United Kingdom

Active ingredients

The drug MYDRIASERT contains a combination of these active pharmaceutical ingredients (APIs):

1 Tropicamide UNII N0A3Z5XTC6 - TROPICAMIDE

Tropicamide is an anticholinergic which blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation thus dilating the pupil (mydriasis). Read about Tropicamide

2 Phenylephrine UNII 04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. Read about Phenylephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FA56	Tropicamide, combinations	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA56

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70710
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 098535
Country: FR	Base de données publique des médicaments	Identifier(s): 67423452
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 198055
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86045